Cobenfy (xanomeline and trospium chloride) — Point32Health

Initial criteria

• Member has a diagnosis of schizophrenia
• AND Member age ≥ 18 years
• AND Member has had an inadequate response or adverse reaction to two atypical antipsychotics, or a contraindication to all alternative generic atypical antipsychotics